TissueGen® Inc., Dallas, Texas, has developed a breakthrough drug-delivery system that consists of polymers that can be integrated into implantable fabrics and medical devices. The polymer technology includes fiber extrusion at room temperature, which preserves the biological activity of therapeutic agents that might be deteriorated under high temperature extrusion techniques. Biomedical Structures LLC, Warwick, R.I., a developer of biomedical textiles, will integrate the polymers into drug-releasing medical devices, such as small diameter vascular grafts and stents, sutures and other implantable technologies. The unique polymer process can be used for many drugs and other therapeutics, such as enzymes and growth factors, and can be custom engineered for specific applications. Drugs are incorporated into the fabrics using commercially available polymer components, including polylactic acid and polydioxanone.
Absorbable polymers deliver medications
Advanced Textiles, Industry News | August 1, 2013 | By: ATA
You might also like...
INDA invites nonwoven professionals to present at IDEA25
Dietz-motoren joins ITMF as corporate member
AAFA announces board of directors leadership for 2024–2025
H&M Group and Vargas Holding launch new venture to scale textile-to-textile recycled polyester
Industry members visit Washington for annual Advocacy Days
Active Apparel Group announces seventh anniversary with FUZE Technologies